Literature DB >> 27642049

The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.

Albert Gubern1, Manel Joaquin1, Miriam Marquès2, Pedro Maseres1, Javier Garcia-Garcia3, Ramon Amat1, Daniel González-Nuñez1, Baldo Oliva3, Francisco X Real2, Eulàlia de Nadal4, Francesc Posas5.   

Abstract

Control of the G1/S phase transition by the Retinoblastoma (RB) tumor suppressor is critical for the proliferation of normal cells in tissues, and its inactivation is one of the most fundamental events leading to cancer. Cyclin-dependent kinase (CDK) phosphorylation inactivates RB to promote cell cycle-regulated gene expression. Here we show that, upon stress, the p38 stress-activated protein kinase (SAPK) maximizes cell survival by downregulating E2F gene expression through the targeting of RB. RB undergoes selective phosphorylation by p38 in its N terminus; these phosphorylations render RB insensitive to the inactivation by CDKs. p38 phosphorylation of RB increases its affinity toward the E2F transcription factor, represses gene expression, and delays cell-cycle progression. Remarkably, introduction of a RB phosphomimetic mutant in cancer cells reduces colony formation and decreases their proliferative and tumorigenic potential in mice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27642049     DOI: 10.1016/j.molcel.2016.08.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  An RB insensitive to CDK regulation.

Authors:  Manel Joaquin; Eulàlia de Nadal; Francesc Posas
Journal:  Mol Cell Oncol       Date:  2016-12-14

2.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

3.  Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.

Authors:  Li-Yuan Yu-Lee; Guoyu Yu; Yu-Chen Lee; Song-Chang Lin; Jing Pan; Tianhong Pan; Kai-Jie Yu; Bin Liu; Chad J Creighton; Jaime Rodriguez-Canales; Pamela A Villalobos; Ignacio I Wistuba; Eulalia de Nadal; Francesc Posas; Gary E Gallick; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2018-03-07       Impact factor: 12.701

4.  Cip1 tunes cell cycle arrest duration upon calcineurin activation.

Authors:  Mackenzie J Flynn; Jennifer A Benanti
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-02       Impact factor: 12.779

Review 5.  Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy.

Authors:  Agnieszka K Witkiewicz; Vishnu Kumarasamy; Ioannis Sanidas; Erik S Knudsen
Journal:  Trends Cancer       Date:  2022-05-20

Review 6.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

7.  Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.

Authors:  Xin Jin; Donglin Ding; Yuqian Yan; Hui Li; Bo Wang; Linlin Ma; Zhenqing Ye; Tao Ma; Qiang Wu; Daniel N Rodrigues; Manish Kohli; Rafael Jimenez; Liguo Wang; David W Goodrich; Johann de Bono; Haidong Dong; Heshui Wu; Runzhi Zhu; Haojie Huang
Journal:  Mol Cell       Date:  2018-12-06       Impact factor: 17.970

8.  LRRC8A-containing chloride channel is crucial for cell volume recovery and survival under hypertonic conditions.

Authors:  Selma A Serra; Predrag Stojakovic; Ramon Amat; Fanny Rubio-Moscardo; Pablo Latorre; Gerhard Seisenbacher; David Canadell; René Böttcher; Michael Aregger; Jason Moffat; Eulàlia de Nadal; Miguel A Valverde; Francesc Posas
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

9.  In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach.

Authors:  Brett Fleisher; Jovin Lezeau; Carolin Werkman; Brehanna Jacobs; Sihem Ait-Oudhia
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-02-18

Review 10.  Stress kinases in the development of liver steatosis and hepatocellular carcinoma.

Authors:  Beatriz Cicuéndez; Irene Ruiz-Garrido; Alfonso Mora; Guadalupe Sabio
Journal:  Mol Metab       Date:  2021-02-13       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.